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mBackground. In this prospective study, we investigated
he determinants of long-term outcome, symptoms, and
eft ventricular function after coronary artery bypass
rafting in patients with a moderate to severely de-
reased left ventricular ejection fraction.
Methods. Between 1997 and 1998, 75 consecutive pa-
ients with moderate to severe left ventricular dysfunc-
ion underwent coronary artery bypass grafting proce-
ures. The operative mortality rate was 4.0%, and the 72
urvivors were monitored for 8 years. The end points
ere mortality, symptomatic status (New York Heart
ssociation [NYHA] functional class), and left ventricu-
ar function.
Results. The total survival rate after 8 years was 89.3%.
uring follow-up, 8 patients died. Death was attributed
o a cardiac cause in 5 patients and to a noncardiac cause
n 3. There was no statistically significant difference
etween preoperative and late postoperative NYHA
unctional class, despite a statistically significant im-
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2008 by The Society of Thoracic Surgeons
ublished by Elsevier Incrovement that persisted for up to 4 years after CABG.
he results of echocardiography showed a statistically
ignificant improvement in the left ventricular ejection
raction (from 0.322  0.06 preoperatively to 0.463  0.02
t follow-up, p < 0.001). Multivariate analysis revealed
hat the left ventricular end-systolic volume index, the
resence of angina pectoris, and absence of symptoms of
ongestive heart failure were preoperative indicators of
reedom from heart failure after coronary operations (p <
.05).
Conclusions. Coronary artery bypass grafting for pa-
ients with moderate-to-severe left ventricular dysfunc-
ion is associated with acceptable long-term results. The
eft ventricular end-systolic volume index is a simple
oninvasive method to aid in the preoperative decision
aking in such patients.
(Ann Thorac Surg 2008;85:488 –93)
© 2008 by The Society of Thoracic Surgeonshe number of patients with advanced left ventricular
dysfunction who undergo coronary artery bypass
rafting (CABG) has increased in the past few years [1].
lthough the recovery of impaired myocardial function
as been shown to occur after CABG, contractile left
entricular dysfunction remains a negative determinant
f postoperative outcome [2]. Impaired left ventricular
unction, which has been shown to be an independent
redictor of operative mortality in patients who undergo
ABG [3], can also lead to low cardiac output and a high
ostoperative mortality rate [4]. Many patients with im-
aired left ventricular function require inotropic or me-
hanical support for hours to days after surgery [4]. In the
ast decade, an improvement in surgical techniques and
erioperative management has led to a better postoper-
tive course and decreased postoperative mortality and
orbidity rates in this high-risk group of patients [5, 6].
Although surgical revascularization may be successful
n the short term, little is known about the long-term
ccepted for publication Sept 10, 2007.
ddress correspondence to Dr Soliman Hamad, Department of Cardio-esults of successful CABG in patients with coronary
rtery disease and left ventricular dysfunction [7]. How-
ver, certain high-risk subgroups of patients remain at
ncreased risk for complications and death despite pro-
ressive advances in perioperative care and myocardial
rotection [8]. We prospectively studied 75 patients with
oderate to severe left ventricular dysfunction who un-
erwent primary elective CABG between 1997 and 1999.
mmediate and short-term results have shown the safety
f CABG in this group of patients [9]. Our study presents
he long-term outcome in this group of patients with
egard to clinical status and predictors of freedom from
ongestive heart failure (CHF).
atients and Methods
etween July 1997 and March 1999, 75 consecutive patients
ith impaired left ventricular function who underwent
ABG in Catharina Hospital, Eindhoven, the Netherlands,
ere enrolled in this prospective study of long-term
utcome. This study was approved by the Medico-Ethical
eview Committee, and an informed consent was signed
y every patient before enrollment. The inclusion criteria
0003-4975/08/$34.00
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Rere the presence of left ventricular dysfunction (ejection
raction [EF]  0.40), isolated CABG, and no acute myo-
ardial infarction during the month that preceded the
peration. Exclusion criteria were prior cardiogenic
hock, emergency surgery, off-pump CABG, implanta-
able 1. Preoperative Characteristics of Patients
atients (n) 75
ge, y (mean  SD) 64 13
ale/female ratio 22/3
YHA functional class, No.
I 15
II 13
III 19
IV 28
reoperative mitral regurgitation, No.
No 46
Trivial 22
Mild 7
reoperative Q-wave MI (30 days),
No.
46
rimary indication for operation, No.
Heart failure 18
Angina 34
Both 10
Ventricular arrhythmia, No. 2
Critical anatomy, No. 11
VESVI (mL/m2)
Mean  SD (range) 86.09 18.9 (61.6–134.2)
Median 78.4
VEF, mean  SD 0.322 0.06
epeat CABG, No. 8
iabetes, No. 19
emodialysis, No. 4
OPD, No. 6
ABG  coronary artery bypass grafting; COPD  chronic obstruc-
ive pulmonary disease; LVEF  left ventricular ejection fraction;
VESVI  left ventricular end-systolic volume index; MI  myocar-
ial infarction; NYHA  New York Heart Association.
able 2. Causes of Postoperative Death in the Study
ubjects
ause of Death Patients, No.
mmediate mortality rate (hospitalized patients)
Low cardiac output 1
Myocardial infarction 1
Mediastinitis 1
-year mortality rate
Cardiac cause
Sudden death 2
Massive pulmonary embolism 1
Noncardiac cause
Cerebral hemorrhage 1
Cancer 1Total 8 C
iion of an intraaortic balloon pump, combined valve
rocedures, or a left ventricular aneurysmectomy. The
reoperative characteristics of the patients studied are
ummarized in Table 1.
reoperative Assessment
ll patients with ventricular dysfunction (EF  0.40 on
ransthoracic-transesophageal echocardiography) and
ibernating myocardium were studied preoperatively.
he presence of this preserved myocyte functional activ-
ty was estimated by a transesophageal echocardiogra-
hy stress test using dobutamine infusion according to
osages and infusion rates as previously described [10].
ibernating myocardium was diagnosed if the patient
ad 5 or more reversible segments of the 16 myocardial
egments [8], and 61 patients (81.3%) had preoperative
vidence of hibernating myocardium.
urgical Techniques
ll patients underwent isolated CABG using cardiopul-
onary bypass. A similar operative technique was per-
ormed throughout the study. After sternotomy and har-
esting of the left internal mammary artery, saphenous
ein, or in selected cases, the radial artery, or both,
ardiopulmonary bypass was initiated with normother-
ic perfusion. Cold St. Thomas crystalloid cardioplegia
as intermittently given through the aortic root. Com-
lete revascularization was achieved in all patients. The
ean cardiopulmonary bypass time was 74 26 minutes,
nd the mean ischemia time was 55  18 minutes.
ig 1. Total survival (dotted line) and freedom from heart failure
solid line) at the 4- and 8-year follow-up. (HF  heart failure.)
able 3. Cardiac Events at Follow-Up
vent Patients, No. Percentage
HF symptoms 24 32
entricular arrhythmia 2 2.7
nfarction 5 6.7
eoperation 0 0
CI 3 4HF  congestive heart failure; PCI  percutaneous coronary
ntervention.
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Rostoperative Follow-Up
he mean follow-up period was 8.1  0.6 years. All
urvivors were clinically monitored in our outpatient
epartment and underwent transthoracic echocardiogra-
hy at 4 and 8 years postoperatively.
The clinical diagnosis of CHF was made if the patient
ad the following criteria (the first two criteria are
ssential):
● History of exertional dyspnea or orthopnea, or
both.
● Clinical examination findings of bilateral basal
crepitation on auscultation, bilateral pitting edema
of the legs, and congested neck veins, with or
without hepatomegaly.
● Clinical response to medical therapy.
tatistical Analysis
he values are presented as the mean  the standard
eviation. Linear mixed models for repeated measures
ere performed to predict the postoperative trend of left
entricular function. The two-sample Student t test was
ig 2. Freedom from heart failure in patients with a preoperative
eft ventricular end-systolic volume index (LVESVI) of 100 mL/m2 or
ess (dashed line) and in those with an LVESVI exceeding 100
L/m2 (solid line). (*p  0.015; **p  0.001; ***p  0.001.)
ig 3. Long-term freedom from heart failure in patients with preop-
rative angina (dashed line) and those without (solid line). (*p 
.01; **p  0.001; ***p  0.001.) ased to test the impact of the individual preoperative
ariables on long-term CHF-free survival. Multivariate
nalysis was applied to determine the independent pre-
ictors of CHF-free survival. We have considered the
ollowing variables in the multivariate analysis: the pres-
nce of hibernating myocardium, presence of preopera-
ive angina, the left ventricular ejection fraction (LVEF),
he left ventricular end-systolic volume index (LVESVI),
nd the New York Heart Association (NYHA) functional
lass. Values of p  0.05 were considered statistically
ignificant. Statistical analysis was performed with SPSS
5.0 software (SPSS Inc, Chicago, IL).
esults
f the 75 patients enrolled in the study, 3 patients (4%)
ied within 30 days of the operation. Five patients (6.7%)
ied during follow-up, and the long-term total survival
ate was 89.3%. The causes of postoperative deaths are
resented in Table 2. Only 1 patient, who emigrated, was
ost to follow-up.
There was a statistically significant improvement in the
VEF during the short-term follow-up, defined as 6
onths after the date of surgery, from 0.32.2%  6.0%
ig 4. Long-term freedom from heart failure in patients at preopera-
ive New York Heart Association (NYHA) functional class III/IV
dashed line) and those at NYHA I/II (solid line). (*p  0.18; **p 
.001; ***p  0.012.)
ig 5. Long-term freedom from heart failure in patients with an pre-
perative ejection fraction (EF) exceeding 0.30 (solid line) and those
t 0.30 or less (dashed line) (*p  0.17; **p  0.12; ***p  0.34).
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Ro 44.0%  4.0% (p  0.0001). However, the results of
ong-term follow-up showed that the postoperative LVEF
id not differ with statistical significance from the imme-
iate postoperative value (mean EF, 0.463  0.02, p 
.12). There was no echocardiographic evidence of post-
perative development of mitral regurgitation or wors-
ning of preexisting mild mitral regurgitation in any
atient.
Freedom from CHF was found in 74.7%  6% of the
atients 4 years after surgery and in 61.3%  8% of the
atients 8 years after surgery (Fig 1). When compared
ith the preoperative value, no statistically significant
mprovement in NYHA class was noted during long-term
ollow-up. Four years after CABG, the number of patients
n NYHA class IV had decreased, with statistical signifi-
ance, from a preoperative rate of 37.7% (n  28) to 24%
n  18) of the total population (p  0.001). Eight years
fter the procedure, the number of patients in NYHA
lass IV significantly increased to 24 patients (32%; p 
.02). All of these patients had preoperative symptoms of
HF.
Nine patients (12%) who exhibited an immediate post-
perative arrhythmia responded to medical therapy, with
he exception of 1 patient who received an implantable
ardiac defibrillator within 2 weeks postoperatively. A
econd patient required the implantation of an implant-
ble cardiac defibrillator 3 years later because of an
pisode of ventricular tachycardia. Postoperative coro-
ary angiography was performed in 14 patients (18.7%)
ue to recurrence of symptoms. Percutaneous coronary
ntervention was performed in 3 patients because of an
ccluded venous graft. No repeat CABG was performed
uring the follow-up period. The cardiac events that
ccurred during long-term follow-up are in Table 3.
Multivariate regression analysis revealed a statistically
ignificant correlation between CHF-free survival and an
VESVI of 100 mL/m2 or less (p 0.001; Fig 2), symptoms
f angina (p 0.001; Fig 3), and preoperative NYHA class
p  0.01; Fig 4). There was no statistically significant
orrelation between CHF-free survival and the preoper-
tive value of the EF (Fig 5) or the presence of hibernating
yocardium. The results of the multivariate analysis are
able 4. Multivariate Predictors of Heart Failure-Free
urvival at 8 Years
ariable Coefficient SE OR 95% CI p Value
YHA class 0.78 0.36 1.2 2.12–6.67 0.03a
ngina 0.64 0.19 2.3 1.03–1.42 0.03a
VESVI 0.32 0.15 0.998 0.997–0.999 0.02a
F 0.004 0.003 0.996 0.991–1.011 0.096
resence of
HM
0.794 0.590 0.995 0.990–0.132 0.077
Statistically significant.
I  confidence interval; EF  ejection fraction; HM  hibernat-
ng myocardium; LVESVI  left ventricular end-systolic volume in-
ex; NYHA  New York Heart Association; SE  standard
rror; OR  odds ratio.n Table 4. tomment
n this study, we showed that CABG in patients affected
y depressed left ventricular function (LVEF  0.40)
onfers a favorable but still not optimal long-term prog-
osis. We observed that surgical revascularization en-
ances left ventricular recovery and ensures long-term
urvival. Recurrent symptoms of CHF were not com-
letely prevented, however; they developed primarily in
atients with a limited functional capacity, those without
reoperative symptoms of angina, and those with an
xtremely dilated ventricle (eg, LVESVI  100 mL/m2).
ssessment of Hibernating Myocardium and Patient
election
redicting the likelihood of myocardial recovery and the
ostoperative prognosis in patients with depressed left
entricular function who underwent CABG remains a
hallenge [11]. Noninvasive tests that establish the pres-
nce and extent of hibernating myocardium are a re-
uirement for accurate patient selection and a favorable
ostoperative result, but those tests are still being refined
12]. In our study, dobutamine stress echocardiography
as performed preoperatively in all patients by the same
ardiologist, and thallium-201 rest-redistribution scintig-
aphy was performed in 43 (57%) patients. Both tech-
iques are valuable in the identification of hibernating
yocardium and in the prediction of a favorable postop-
rative outcome [13].
We confirmed in earlier research [9] that the preoper-
tive presence of hibernating myocardium is a predictor
f immediate postoperative improvement of left ventric-
lar function in these patients. However, we found that
ibernating myocardium had no predictive value with
espect to long-term outcome. Freedom from heart fail-
re was not statistically significantly correlated with the
reoperative presence of hibernating myocardium.
The predictive role of the preoperative assessment of a
iable myocardium has been confirmed by several au-
hors [8, 14, 15]. Kron, commenting on the study by Chan
nd colleagues [8], noted that the problem of postopera-
ive deterioration lies in patients who have no evidence
f ischemia and hence do not benefit from revasculariza-
ion. Elefteriades and colleagues [16] suggested that myo-
ardial viability should be considered as a continuum
from full thickness viability without any scar to full
hickness scarring without viable cells.” To confirm this,
reoperative viability studies (dobutamine stress-
chocardiography or thallium) should be correlated with
he histologic results of biopsied cardiac tissue.
atient Survival
ata on the long-term results of CABG in patients with
mpaired left ventricular function are few [13, 17]; there-
ore, we conducted this prospective study of selected
atients with compromised left ventricular function.
ight years after CABG, 89.3% of the patients in our
eries were alive. CHF-free survival after CABG was
4.7% at 4 years and 61.3% at 8 years (an outcome better
han that of previous series) [7]. However, those studies
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Rncluded patients without established hibernating myo-
ardium at the preoperative assessment [7]. A surprising
nding was that the presence of hibernating myocardium
as not a statistically significant predictor of long-term
urvival in our patients. Hibernating myocardium may
ave more greatly affected the immediate postoperative
utcome than the long-term outcome, a theory supported
y the fact that an immediate postoperative improve-
ent in left ventricular function indicators was not fol-
owed by a further improvement in late follow-up.
ecovery of Left Ventricular Function and Recurrence
f Heart Failure
ur data showed a substantial improvement in left
entricular function after revascularization. However,
hen we compared the recovery of left ventricular func-
ion in long-term follow-up with immediate postopera-
ive improvement, we noted no statistically significant
hange. Shivalkar and colleagues [18] showed that the
yocardial structure of the hypocontractile segments has
critical role in functional recovery. The extent of hiber-
ating myocardium appears to be a positive predictor of
eft ventricular functional improvement after CABG. The
resence of a well-developed coronary collateral net has
lso been shown to predict the resumption of segmental
all motion [19].
Revascularization reduces postoperative mortality and
orbidity in these patients but does not protect against
he progression of ischemic cardiomyopathy in some of
hem. The time-limited beneficial effects of revasculariza-
ion in patients with left ventricular dysfunction have
lso been shown by Luciani and colleagues [20], who
oted that 47% of the patients studied were free of the
ymptoms of heart failure 5 years after CABG, despite an
bsolute survival rate of 75% for that time period. In their
eries, only 48% of the patients had undergone a preop-
rative assessment of myocardial viability; this rendered
he need for CABG in patients with irreversible myocar-
ial damage likely. Further homogenous clinical series
re needed to further elucidate the optimal patient selec-
ion for the treatment of ischemic cardiomyopathy.
redictors of Late Outcome
n our series, preoperative symptoms of ischemia and
HF appeared to be the most statistically significant
redictors of long-term outcome. Our finding supports
he observation of Lansman and colleagues [21], who
tated that the presence of angina predicted a good
urvival rate and a consistent improvement in left ven-
ricular function. However, other investigators [13] have
hown that the presence of angina had no statistically
ignificant predictive value with regard to long-term
ortality and the recurrence of heart failure.
Dreyfus and colleagues [22] emphasized the impor-
ance of using viability tests instead of clinical evaluation
s a crucial determinant of patient selection and subse-
uent postoperative outcome. In our series, hibernating
yocardium was a statistically significant predictor ofmmediate postoperative recovery, but the preoperativeschemia class and NYHA functional class were statisti-
ally significant predictors of long-term outcome.
The LVESVI proved to be an important predictor of
oth short- and long-term functional improvement in our
eries. In patients who had a preoperative LVESVI of 100
L/m2 or less, we observed a favorable outcome for
urvival and the recovery of left ventricular function.
hat finding supports the conclusion of other investiga-
ors [23, 24] who noted that the LVESVI was the only
ndependent measurement that was predictive of sur-
ival and the improvement of left ventricular function.
he LVESVI is a simple and noninvasive preoperative
redictor of postoperative functional recovery. It can be
olely used in the decision making in patients with
schemic cardiomyopathy; however, further studies with
arger groups of patients are needed to confirm this
tatement. On the other hand, the EF value was not a
tatistically significant predictor of long-term outcome in
ur series. Like other authors [25], we observed that the
F was not a strong predictor of outcome in patients with
evere left ventricular dysfunction. That theory rests on
he fact that a low EF did not differentiate between
ibernation and infarction as the cause of poor contrac-
ile function.
In conclusion, we found that revascularization con-
erred a low postoperative mortality rate and a potential
enefit to left ventricular function in patients with im-
aired left ventricular function. The long-term survival
ate in our series was better than that in previous series.
e found that long-term freedom from heart failure
ould be predicted by the preoperative presence of
ngina and a preoperative LVESVI of 100 mL/m2 or less.
he presence of preoperative NYHA class III or IV was a
redictor of a less favorable long-term outcome.
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